Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
The Health IT Policy Committee’s work groups are going through an evolution, according to National Coordinator for Health IT Karen DeSalvo, MD, MPH, MSc, during the committee’s April 8 meeting.
The University of North Carolina Internal Medicine Clinic reduced its 30-day readmissions by approximately 65 percent by implementing a care-based follow-up program.
During the April 8 Health IT Policy Committee, the co-chairs of the new Accountable Care Work Group detailed their outlook for the committee and its goals.
The ECRI Institute Patient Safety Organization has launched The Partnership for Promoting Health IT Patient Safety, a multi-stakeholder group that seeks to generate new knowledge on safe health IT practices.
More than one million patients in Oregon and Southwest Washington will have electronic access to provider notes in their EHRs as part of a collaboration between nine health systems and medical groups and We Can Do Better, a nonprofit committed to practicing open notes.
The Office of the National Coordinator for Health IT has renewed its cooperative agreement contract with DirectTrust, a nonprofit trade alliance that promotes the Direct Protocol, for an additional year.
The Health IT Policy Committee formally endorsed best practices regarding the Meaningful Use Stage 2 requirement to allow patients to view, download and transmit their personal health information to family, friends and personal representatives of adult patients.
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.
The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks.
Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.
